Comparison of fasting and post prandial lipid profile in patients of IHD

 

 

REFERENCES

1. Rosenson RS. Hypertriglyceridemia and coronary heart disease risk. Cardiol Rev 1999; 7: 342-8.
2. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60: 473-85.
3. Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Philadelphia, Pa: Elsevier Saunders; 2006:903–982.
4. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486 –2497.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger C, V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601–1610.
6. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988;29:469–479.
7. Schaefer EJ, Audelin MC, McNamara JR, Shah PK, Tayler T, Daly JA, Augustin JL, Seman LJ, Rubenstein JJ. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol. 2001;88:1129 –1133.
8. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309 –316.
9. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299 –308.
10. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation 1979; 60: 473-85.
11. Bae JH, Schwemmer M, Lee IK, et al. Postprandial hypertriglyceridemia induced endothelial dysfunction in healthy subjects is independent of lipid oxidation. Int J Cardiol 2003; 87: 259-67.
12. Ernst JS, Marie CA, Judith R, et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am J Cardiol 2001; 88: 1129-33.
13. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium dependent brachial artery vasoactivity following a single high fat meal. J Am Med Assoc 1997; 278: 1682-6.
14. Kugiyama K, Doi H, Motoyama T, et al. Association of remnant lipoprotein levels with impairment of endothelium dependent vasomotor function in human coronary arteries. Circulation 1998; 97: 2519-26.
15. Orekhov AN, Tertov VV, Mukhin DN. Desialyated low density lipoprotein- naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis 1991; 86: 153-61.
16. Gordel T, Castelli WP, Hjortlaud MC. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-14.
17. McGowan MW, Artiss JD, Strandbergh DR. A peroxidase coupled method for the colorimetricdetermination of serum triglycerides. Clin Chem 1983; 29: 38-542.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-504.
19. Vijay Shankar, Harnam Kaur, Kiran Dahiya, MS Gupta. Comparison of Fasting and Postprandial Lipid Profile in Patients of Coronary Heart Disease. Bombay Hospital Journal,2008; 50(3):445-49.
20. Jarret RJ. The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 1996; 13:15-9.
21. Balkau B, Bertrais S, Ducimetiere P, et al. Is there a glycemic threshold for mortality risk? Diabetes Care 1999; 22: 696-99.
22. Shaikh M, Wootton R, Nordestgaard BG, et al. Quantitative studies of transfer in vivo of low density, Sf 12-60 and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb 1991; 11 : 569-77.
23. Patsch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb Vasc Biol 1992; 12 : 1336-45.
24. Bjorkegren J, Boquist S, Samnegard A, et al. Accumulation of apolipoprotein C-1 rich and cholesterol rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease. Circulation 2000; 101 : 227-30.
25. Sharrett AR, Heiss G, Chambless LE, et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides. The Atherosclerosis risk in communities (ARIC) study. Arteioscler Thromb Vasc Biol 2001; 21 : 275-81.
26. Roche HM, Gibney MJ. The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 2000; 7 : 317-24.
27. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999; 246 : 341-55.
28. Ayyappan S, Kalyananibehra A and Ilanchezhian T: Comparison of post prandial lipid profile at an interval of 2 hours and 4 hours in patients of coronary heart disease. Int J Pharm Sci Res 2017; 8(4): 1846-49
29. Boccalandro F, Farias J, Boccalandro C, Vaisman D. Frequency of postprandial lipemia after a first acute coronary event (unstable angina pectoris or non-ST-segment elevation acute myocardial infarction) and the effects of atenolol on the lipemia. Am J Cardiol. 2002; 90(2):153-6.
30. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on a. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult b. Treatment Panel III) final report. Circulation. 2002; 106 (25): 3143-421.